Growth Metrics

Hinge Health (HNGE) Return on Sales (2024 - 2026)

Hinge Health recorded quarterly Return on Sales of 0.0% in Q1 2026, up 2.5% quarter-over-quarter from 0.0% in Q4 2025, and little changed year-over-year from 0.0% in Q1 2025.

Hinge Health's Return on Sales history runs 3 years deep, the most recent figure standing at 0.0% for Q1 2026.

  • In Q1 2026, Return on Sales changed 0.0% year-over-year to 0.0%; the TTM figure through Mar 2026 stood at 0.01% (down 1.0% YoY), while the FY2025 annual figure was 0.01%, down 1.0% from the prior year.
  • Return on Sales came in at 0.0% for Q1 2026 at Hinge Health, up from 0.0% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.0% in Q4 2024 to a low of 0.04% in Q2 2025.
  • A 3-year average of 0.0% and a median of 0.0% in 2024 frame the typical range for Return on Sales.
  • On a YoY basis, Return on Sales climbed as much as 0 bps in 2025 and fell as far as 4 bps in 2025.
  • Hinge Health's Return on Sales stood at 0.0% in 2024, then dropped by 19 bps to 0.0% in 2025, then grew by 2 bps to 0.0% in 2026.
  • According to Business Quant data, Return on Sales over the past three periods registered 0.0%, 0.0%, and 0.0% for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Veeva Systems 30.85 Bn 24.28 Bn 622.47 Mn 0.00%
2 BrightSpring Health Services 12.29 Bn 11.41 Bn 482.22 Mn 0.00%
3 Healthequity 7.80 Bn 7.48 Bn 256.31 Mn 0.00%
4 Hinge Health 4.82 Bn 4.51 Bn 154.23 Mn 0.00%
5 Doximity 4.21 Bn 3.46 Bn 125.97 Mn 0.00%
6 Waystar Holding 4.18 Bn 4.03 Bn 268.04 Mn 0.00%
7 10x Genomics 3.78 Bn 3.24 Bn 106.18 Mn 0.00%
8 Privia Health 2.65 Bn 2.28 Bn 595.71 Mn 0.00%
9 Omnicell 1.95 Bn 1.78 Bn 140.36 Mn 0.00%
10 Teladoc Health 1.42 Bn 672.39 Mn 562.57 Mn 0.00%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 0.00%
Dec 31, 2025 0.00%
Sep 30, 2025 0.00%
Jun 30, 2025 -0.04%
Mar 31, 2025 0.00%
Dec 31, 2024 0.00%
Sep 30, 2024 0.00%
Jun 30, 2024 0.00%